tiprankstipranks
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO

Mereo Biopharma Group Plc (MREO) Balance Sheet

471 Followers

Mereo Biopharma Group Plc Balance Sheet

Mereo Biopharma Group Plc's total assets for Q4 2022 were £88.08M, a decrease of -30.33% from the previous quarter. MREO total liabilities were £26.21M for the fiscal quarter, a -31.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
£ 88.08M£ 126.42M£ 62.95M£ 86.45M£ 67.28M
Total Liabilities
£ 26.21M£ 38.41M£ 77.92M£ 46.19M£ 34.51M
Total Equity Gross Minority
£ 61.87M£ 88.00M£ -14.97M£ 40.26M£ 32.77M
Total Capitalization
£ 61.87M£ 102.39M£ 1.17M£ 45.63M£ 47.42M
Preferred Stock Equity
-----
Capital Lease Obligations
--£ 1.79M£ 11.90M£ 0.00
Currency in GBP

Mereo Biopharma Group Plc Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis